Copyright Reports & Markets. All rights reserved.

Global Drug for Ulcerative Colitis Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Drug for Ulcerative Colitis Market Overview

      • 1.1 Product Overview and Scope of Drug for Ulcerative Colitis
      • 1.2 Drug for Ulcerative Colitis Segment by Type
        • 1.2.1 Global Drug for Ulcerative Colitis Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Injection
      • 1.3 Drug for Ulcerative Colitis Segment by Application
        • 1.3.1 Drug for Ulcerative Colitis Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Drugs Stores
      • 1.4 Global Drug for Ulcerative Colitis Market by Region
        • 1.4.1 Global Drug for Ulcerative Colitis Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Drug for Ulcerative Colitis Market Size
        • 1.5.1 Global Drug for Ulcerative Colitis Revenue (2014-2025)
        • 1.5.2 Global Drug for Ulcerative Colitis Production (2014-2025)

      2 Global Drug for Ulcerative Colitis Market Competition by Manufacturers

      • 2.1 Global Drug for Ulcerative Colitis Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Drug for Ulcerative Colitis Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Drug for Ulcerative Colitis Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Drug for Ulcerative Colitis Production Sites, Area Served, Product Types
      • 2.5 Drug for Ulcerative Colitis Market Competitive Situation and Trends
        • 2.5.1 Drug for Ulcerative Colitis Market Concentration Rate
        • 2.5.2 Drug for Ulcerative Colitis Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Drug for Ulcerative Colitis Production Market Share by Regions

      • 3.1 Global Drug for Ulcerative Colitis Production Market Share by Regions
      • 3.2 Global Drug for Ulcerative Colitis Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Drug for Ulcerative Colitis Production
        • 3.4.1 North America Drug for Ulcerative Colitis Production Growth Rate (2014-2019)
        • 3.4.2 North America Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Drug for Ulcerative Colitis Production
        • 3.5.1 Europe Drug for Ulcerative Colitis Production Growth Rate (2014-2019)
        • 3.5.2 Europe Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Drug for Ulcerative Colitis Production (2014-2019)
        • 3.6.1 China Drug for Ulcerative Colitis Production Growth Rate (2014-2019)
        • 3.6.2 China Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Drug for Ulcerative Colitis Production (2014-2019)
        • 3.7.1 Japan Drug for Ulcerative Colitis Production Growth Rate (2014-2019)
        • 3.7.2 Japan Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Drug for Ulcerative Colitis Consumption by Regions

      • 4.1 Global Drug for Ulcerative Colitis Consumption by Regions
      • 4.2 North America Drug for Ulcerative Colitis Consumption (2014-2019)
      • 4.3 Europe Drug for Ulcerative Colitis Consumption (2014-2019)
      • 4.4 China Drug for Ulcerative Colitis Consumption (2014-2019)
      • 4.5 Japan Drug for Ulcerative Colitis Consumption (2014-2019)

      5 Global Drug for Ulcerative Colitis Production, Revenue, Price Trend by Type

      • 5.1 Global Drug for Ulcerative Colitis Production Market Share by Type (2014-2019)
      • 5.2 Global Drug for Ulcerative Colitis Revenue Market Share by Type (2014-2019)
      • 5.3 Global Drug for Ulcerative Colitis Price by Type (2014-2019)
      • 5.4 Global Drug for Ulcerative Colitis Production Growth by Type (2014-2019)

      6 Global Drug for Ulcerative Colitis Market Analysis by Applications

      • 6.1 Global Drug for Ulcerative Colitis Consumption Market Share by Application (2014-2019)
      • 6.2 Global Drug for Ulcerative Colitis Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Drug for Ulcerative Colitis Business

      • 7.1 Johnson & Johnson.
        • 7.1.1 Johnson & Johnson. Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.1.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.1.3 Johnson & Johnson. Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 AbbVie
        • 7.2.1 AbbVie Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.2.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.2.3 AbbVie Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Takeda Pharmaceuticals
        • 7.3.1 Takeda Pharmaceuticals Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.3.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.3.3 Takeda Pharmaceuticals Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Roche
        • 7.4.1 Roche Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.4.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.4.3 Roche Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Warner Chilcott
        • 7.5.1 Warner Chilcott Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.5.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.5.3 Warner Chilcott Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Salix Pharmaceuticals/Santarus
        • 7.6.1 Salix Pharmaceuticals/Santarus Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.6.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.6.3 Salix Pharmaceuticals/Santarus Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Shire Pharmaceuticals
        • 7.7.1 Shire Pharmaceuticals Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.7.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.7.3 Shire Pharmaceuticals Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Ferring Pharmaceuticals
        • 7.8.1 Ferring Pharmaceuticals Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.8.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.8.3 Ferring Pharmaceuticals Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Pfizer
        • 7.9.1 Pfizer Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.9.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.9.3 Pfizer Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 InDeX Pharmaceuticals
        • 7.10.1 InDeX Pharmaceuticals Drug for Ulcerative Colitis Production Sites and Area Served
        • 7.10.2 Drug for Ulcerative Colitis Product Introduction, Application and Specification
        • 7.10.3 InDeX Pharmaceuticals Drug for Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Drug for Ulcerative Colitis Manufacturing Cost Analysis

      • 8.1 Drug for Ulcerative Colitis Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Drug for Ulcerative Colitis
      • 8.4 Drug for Ulcerative Colitis Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Drug for Ulcerative Colitis Distributors List
      • 9.3 Drug for Ulcerative Colitis Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Drug for Ulcerative Colitis Market Forecast

      • 11.1 Global Drug for Ulcerative Colitis Production, Revenue Forecast
        • 11.1.1 Global Drug for Ulcerative Colitis Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Drug for Ulcerative Colitis Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Drug for Ulcerative Colitis Price and Trend Forecast (2019-2025)
      • 11.2 Global Drug for Ulcerative Colitis Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Drug for Ulcerative Colitis Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Drug for Ulcerative Colitis Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Drug for Ulcerative Colitis Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Drug for Ulcerative Colitis Production, Revenue Forecast (2019-2025)
      • 11.3 Global Drug for Ulcerative Colitis Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Drug for Ulcerative Colitis Consumption Forecast (2019-2025)
        • 11.3.2 Europe Drug for Ulcerative Colitis Consumption Forecast (2019-2025)
        • 11.3.3 China Drug for Ulcerative Colitis Consumption Forecast (2019-2025)
        • 11.3.4 Japan Drug for Ulcerative Colitis Consumption Forecast (2019-2025)
      • 11.4 Global Drug for Ulcerative Colitis Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Drug for Ulcerative Colitis Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).

        The global Drug for Ulcerative Colitis market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Drug for Ulcerative Colitis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug for Ulcerative Colitis market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Johnson & Johnson.
        AbbVie
        Takeda Pharmaceuticals
        Roche
        Warner Chilcott
        Salix Pharmaceuticals/Santarus
        Shire Pharmaceuticals
        Ferring Pharmaceuticals
        Pfizer
        InDeX Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Oral
        Injection

        Segment by Application
        Hospital
        Drugs Stores

        Buy now